医学
肥厚性心肌病
心脏病学
内科学
梗阻性心肌病
作者
Ahmad Masri,Lubna Choudhury,Roberto Barriales‐Villa,Perry Elliott,Martin S. Maron,Michael E. Nassif,Artur Oręziak,Anjali Owens,Sara Saberi,Albree Tower‐Rader,Florian Rader,Pablo García‐Pavía,Iacopo Olivotto,Sherif F. Nagueh,Andrew Z. Wang,Stephen B. Heitner,Daniel Jacoby,Stuart Kupfer,Fady I. Malik,Chiara Melloni
标识
DOI：10.1016/j.jacc.2024.09.002
摘要
Standard-of-care (SoC) medications for the treatment of obstructive hypertrophic cardiomyopathy (oHCM) are recommended as first-line therapy despite the lack of evidence from controlled clinical trials and well known off-target side effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI
Grayball
浦肯野
MchemG
nozero
pcr163
andrele
小透明
YifanWang
brian0326
从容芮
醉书生
Oracle
CAOHOU
JPH1990
VDC
NJD
复杂书竹
zinnn
子凡
shinysparrow
皖公网安备34019202002308
